Altogether, the results presented here indicate that KLRG1, BTK, CCR2 and SCML4 play important roles in the development of lung adenocarcinoma, and their expression can be effective biomarkers to predict LUAD patients’ survival. Here, KLRG1 is linked to lung adenocarcinoma.